OncoCyte Corporation

Q2 2024 13F Holders

Symbol
IMDX
CUSIP
68235C206
Type
Equity
Class
COM NEW
Num filings
25
Total reported value, excl. options
$17.9 M
Manager Report Date Value ($000) Shares Option Type